PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsLevalbuterol
Levosalbutamol
Levosalbutamol is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target beta-2 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
661 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AsthmaD001249EFO_0000270J451957937077313
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9517523349154
Obstructive lung diseasesD008173214482135118
Lung diseasesD008171EFO_0003818J98.4313462325109
Healthy volunteers/patients13121329
BronchiolitisD00198833151325
Status asthmaticusD0132242544618
Respiratory aspirationD053120EFO_10018392156418
Bronchial spasmD001986243312
Respiratory soundsD012135R06.1114410
Show 46 more
Indications Phases 3
Indications Phases 2
Indications Phases 1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
SmokingD012907EFO_000431844
Airway remodelingD05615133
EmphysemaD004646EFO_0000464J4333
InfectionsD007239EFO_000054433
Chronic bronchitisD029481J4222
Muscular dystrophiesD009136EFO_0000757G71.022
Child mortalityD04668822
Noninvasive ventilationD06308722
Artificial respirationD01212111
Pulmonary atelectasisD001261J98.111
Show 72 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLevosalbutamol
INNlevosalbutamol
Description
(R)-salbutamol is an albuterol.
Classification
Small molecule
Drug classanti-inflammatory agents (salicylic acid derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1
Identifiers
PDB
CAS-ID34391-04-3
RxCUI
ChEMBL IDCHEMBL1002
ChEBI ID8746
PubChem CID123600
DrugBankDB13139
UNII IDEDN2NBH5SS (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
ADRB2
ADRB2
Organism
Homo sapiens
Gene name
ADRB2
Gene synonyms
ADRB2R, B2AR
NCBI Gene ID
Protein name
beta-2 adrenergic receptor
Protein synonyms
adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, Beta-2 adrenoceptor, Beta-2 adrenoreceptor, catecholamine receptor
Uniprot ID
Mouse ortholog
Adrb2 (11555)
beta-2 adrenergic receptor (Q8BH38)
Variants
No data
Financial
Revenue by drug
$
£
No data
Estimated US medical usage
Levosalbutamol
+
Levalbuterol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,342 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use